You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

三葉草生物-B(02197.HK)啓動COVID-19加強劑II期試驗

阿思達克 11-26 09:17
三葉草生物-B(02197.HK)公佈,啓動一項由研究人員主導的II期試驗,以評估異源及同源COVID-19加強劑的免疫原性及安全性。公司之COVID-19候選疫苗SCB-2019(CpG1018加鋁佐劑)將作爲先前接種過CoronaVac疫苗或重組Covid-19疫苗(阿斯利康/Fiocruz)的個體的異源加強劑進行評估。